These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 25227555)
1. Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. Rodriguez-Poncelas A; Coll-De Tuero G; Turrò-Garriga O; Barrot-de la Puente J; Franch-Nadal J; Mundet-Tuduri X; BMC Nephrol; 2014 Sep; 15():150. PubMed ID: 25227555 [TBL] [Abstract][Full Text] [Related]
2. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study. Fung CS; Wan EY; Chan AK; Lam CL BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985 [TBL] [Abstract][Full Text] [Related]
3. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus. Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J; Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301 [TBL] [Abstract][Full Text] [Related]
4. Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort. Choi Y; Jacobs DR; Shroff GR; Kramer H; Chang AR; Duprez DA J Am Heart Assoc; 2022 Nov; 11(21):e026685. PubMed ID: 36314497 [TBL] [Abstract][Full Text] [Related]
5. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study. Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575 [TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification. Wang T; Xi Y; Lubwama R; Hannanchi H; Iglay K; Koro C Diabetes Metab Syndr; 2019; 13(1):612-615. PubMed ID: 30641775 [TBL] [Abstract][Full Text] [Related]
7. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease. Jespersen T; Kruse N; Mehta T; Kuwabara M; Noureddine L; Jalal D Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1133-1139. PubMed ID: 30143406 [TBL] [Abstract][Full Text] [Related]
8. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults. Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. Rodriguez-Poncelas A; Garre-Olmo J; Franch-Nadal J; Diez-Espino J; Mundet-Tuduri X; Barrot-De la Puente J; Coll-de Tuero G; BMC Nephrol; 2013 Feb; 14():46. PubMed ID: 23433046 [TBL] [Abstract][Full Text] [Related]
10. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort. Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992 [TBL] [Abstract][Full Text] [Related]
11. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease. Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176 [TBL] [Abstract][Full Text] [Related]
12. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression. Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M Am J Kidney Dis; 2021 Sep; 78(3):350-360.e1. PubMed ID: 33895181 [TBL] [Abstract][Full Text] [Related]
13. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes. Filippatos G; Anker SD; Pitt B; Rossing P; Joseph A; Kolkhof P; Lambelet M; Lawatscheck R; Bakris GL; Ruilope LM; Agarwal R JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655 [TBL] [Abstract][Full Text] [Related]
14. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961 [TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population. Lim CC; Teo BW; Ong PG; Cheung CY; Lim SC; Chow KY; Meng CC; Lee J; Tai ES; Wong TY; Sabanayagam C Eur J Prev Cardiol; 2015 Aug; 22(8):1018-26. PubMed ID: 24857889 [TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study. Gao Z; Zhu Y; Sun X; Zhu H; Jiang W; Sun M; Wang J; Liu L; Zheng H; Qin Y; Zhang S; Yang Y; Xu J; Yang J; Shan C; Chang B Front Endocrinol (Lausanne); 2022; 13():1064665. PubMed ID: 36578951 [TBL] [Abstract][Full Text] [Related]
17. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. Hermans MM; Henry R; Dekker JM; Kooman JP; Kostense PJ; Nijpels G; Heine RJ; Stehouwer CD J Am Soc Nephrol; 2007 Jun; 18(6):1942-52. PubMed ID: 17460143 [TBL] [Abstract][Full Text] [Related]
18. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease. Su W; Chen M; Xiao L; Du S; Xue L; Feng R; Ye W Front Public Health; 2022; 10():1047794. PubMed ID: 36420005 [TBL] [Abstract][Full Text] [Related]
19. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone. Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801 [TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk. Verhagen C; Janssen J; Minderhoud CA; van den Berg E; Wanner C; Passera A; Johansen OE; Biessels GJ J Diabetes Complications; 2022 Oct; 36(10):108303. PubMed ID: 36116359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]